Log In
BCIQ
Print this Print this
 

Dihydrofolate reductase (DHFR)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Dihydrofolate reductase (DHFR)

BCIQ
Print ChartPrint this
Marketed, 2 Marketed, 3 Marketed, 1 Phase III, 1 Phase III, 1 Phase II, 1 Phase I, 1 Preclinical, 1 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IPhase IIPhase IIIMarketed
Autoimmune

-

-

-

-

1

Cancer

1

1

1

1

3

Infectious

1

-

-

1

2




 Products Targeting Dihydrofolate reductase (DHFR)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

9

$876.2M

$305.7M

$312.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today